One of the problems IMU and CHM are facing is the market not understanding that the complete responses across all their platforms have been achieved as 3rd, 4th or even 5th line of treatment. We are not talking about cancer stage 1, it is stage 3/4 and death row.
Plus, as so important these days but not recognised by the market either is DURABILITY and speed. Achieving a CR after a month and the previous one still being a CR shows the importance and difference of both companies' technologies.
The gap between the progress / data and the falling valuations is widening day by day - at some stage someone has to step up and has to sell / tell the market or the industry leaders. There are hundreds of great results achieved and reported everyday worldwide, one has to stand up and has to trumpet those incredible results to the world - otherwise the dismal financial performance of IMU and RAD will continue.
I made a few suggestions to the board on Friday, not sure if any of the members cares but last week's sh demands were suddenly met, maybe some of the decision makers will have at least a look at it. Can't get worse, or can it?
If Hopper comes out with a 1c cap raising then we know who the weakest link is.
GLTA
CHM Price at posting:
1.4¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)